Skip to content

Perspective Therapeutics CATX Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$31K-49.2%
Immunome logo
ImmunomeIMNM
$5.36M+23.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$888K+81.6%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$92.1M+153%
uniQure logo
uniQureQURE
$30.15M+455%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's other non-current assets?
Perspective Therapeutics (CATX) reported other non-current assets of $490K in Q1 2026.
How has Perspective Therapeutics's other non-current assets changed year-over-year?
Perspective Therapeutics's other non-current assets increased by 33.9% year-over-year, from $366K to $490K.
What is the long-term trend for Perspective Therapeutics's other non-current assets?
Over 5 years (2020 to 2025), Perspective Therapeutics's other non-current assets has grown at a 32.5% compound annual growth rate (CAGR), from $119K to $486K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.